Chu Nantes Hopital Nord Laennec

SaintHerblain 44805

1 studies enrolling now · 4 studies all time

What they study most

Advanced Solid Tumor, Diffuse Large B Cell Lymphoma, Endometrial Cancer, Lymphoma, T-Cell, Mesothelioma, Malignant, Metastatic Castration-resistant Prostate Cancer, Metastatic Non-small Cell Lung Cancer, NSCLC, Non-small Cell Lung Cancer, Ovarian Clear Cell Carcinoma, Prostatic Neoplasms, Castration-Resistant, Severe Hypertriglyceridemia

Studies at this site

• A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas — Recruiting now
• A Study of Ociperlimab With Tislelizumab Compared to Pembrolizumab in Participants With Untreated Lung Cancer — Stopped early
• A Study of Tislelizumab in Combination With Investigational Agents in Participants With Non-Small Cell Lung Cancer — Running, not enrolling
• A Study of Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia — Completed